Detalles de la búsqueda
1.
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
Blood
; 141(2): 156-167, 2023 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35714312
2.
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001.
Br J Haematol
; 204(3): 877-886, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952982
3.
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
Am J Hematol
; 99(2): 254-262, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108611
4.
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
JAMA
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722621
5.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36692409
6.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335916
7.
Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
Haematologica
; 108(7): 1793-1802, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779592
8.
Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.
Haematologica
; 2023 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38058184
9.
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Ann Hematol
; 102(5): 1099-1109, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959485
10.
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica
; 107(9): 2064-2071, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142153
11.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
Hematol Oncol
; 40(4): 734-742, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35618655
12.
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.
Eur J Haematol
; 108(6): 449-459, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35156731
13.
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Br J Haematol
; 193(2): 271-279, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403687
14.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica
; 106(6): 1559-1568, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32467145
15.
Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial.
Ann Hematol
; 100(5): 1181-1194, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740113
16.
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
Acta Haematol
; 144(6): 688-692, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34130278
17.
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.
Eur J Haematol
; 105(1): 47-55, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145118
18.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Am J Hematol
; 95(12): 1466-1472, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777149
19.
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia.
Future Oncol
; 16(13): 807-815, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32167393
20.
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery.
Cancer
; 125(5): 712-725, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30480765